EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation
S Song, R Zhang, B Mo, L Chen, L Liu, Y Yu… - Journal of molecular and …, 2019 - Elsevier
Abstract Angiotensin II (Ang-II)-induced fibroblast differentiation plays an important role in
the development of atrial fibrosis and atrial fibrillation (AF). Here, we show that the …
the development of atrial fibrosis and atrial fibrillation (AF). Here, we show that the …
EZH2 as a Novel Therapeutic Target for Atrial Fibrosis and Atrial Fibrillation
S Song, Q Wang - Circulation, 2019 - Am Heart Assoc
Introduction: Atrial fibrillation (AF) is characterized by abnormal differentiation of atrial
fibroblasts and excessive deposition of extracellular matrix (ECM). Several studies …
fibroblasts and excessive deposition of extracellular matrix (ECM). Several studies …
EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation.
S Song, R Zhang, B Mo, L Chen, L Liu, Y Yu… - Journal of Molecular …, 2019 - europepmc.org
Angiotensin II (Ang-II)-induced fibroblast differentiation plays an important role in the
development of atrial fibrosis and atrial fibrillation (AF). Here, we show that the expression of …
development of atrial fibrosis and atrial fibrillation (AF). Here, we show that the expression of …
EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation
S Song, R Zhang, B Mo, L Chen… - … of molecular and …, 2019 - pubmed.ncbi.nlm.nih.gov
Angiotensin II (Ang-II)-induced fibroblast differentiation plays an important role in the
development of atrial fibrosis and atrial fibrillation (AF). Here, we show that the expression of …
development of atrial fibrosis and atrial fibrillation (AF). Here, we show that the expression of …